224 related articles for article (PubMed ID: 24914786)
1. Conservative management of vestibular schwannoma: expectations based on the length of the observation period.
Fayad JN; Semaan MT; Lin J; Berliner KI; Brackmann DE
Otol Neurotol; 2014 Aug; 35(7):1258-65. PubMed ID: 24914786
[TBL] [Abstract][Full Text] [Related]
2. Ten-Year Follow-up on Tumor Growth and Hearing in Patients Observed With an Intracanalicular Vestibular Schwannoma.
Kirchmann M; Karnov K; Hansen S; Dethloff T; Stangerup SE; Caye-Thomasen P
Neurosurgery; 2017 Jan; 80(1):49-56. PubMed ID: 27571523
[TBL] [Abstract][Full Text] [Related]
3. Durability of Hearing Preservation Following Microsurgical Resection of Vestibular Schwannoma.
Dowling EM; Patel NS; Lohse CM; Driscoll CLW; Neff BA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2019 Dec; 40(10):1363-1372. PubMed ID: 31725593
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
[TBL] [Abstract][Full Text] [Related]
5. Length of tumor-cochlear nerve contact and hearing outcome after surgery for vestibular schwannoma.
Yong RL; Westerberg BD; Dong C; Akagami R
J Neurosurg; 2008 Jan; 108(1):105-10. PubMed ID: 18173318
[TBL] [Abstract][Full Text] [Related]
6. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
7. Middle fossa decompression for hearing preservation: a review of institutional results and indications.
Slattery WH; Hoa M; Bonne N; Friedman RA; Schwartz MS; Fisher LM; Brackmann DE
Otol Neurotol; 2011 Aug; 32(6):1017-24. PubMed ID: 21725256
[TBL] [Abstract][Full Text] [Related]
8. Conservative management of vestibular schwannoma: Predictors of growth and hearing.
Jethanamest D; Rivera AM; Ji H; Chokkalingam V; Telischi FF; Angeli SI
Laryngoscope; 2015 Sep; 125(9):2163-8. PubMed ID: 25647714
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Hearing Preservation Outcomes for Small Vestibular Schwannomas: Retrosigmoid Removal Versus Observation.
Zhu W; Chen H; Jia H; Chai Y; Yang J; Wang Z; Wu H
Otol Neurotol; 2018 Feb; 39(2):e158-e165. PubMed ID: 29315192
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation in vestibular schwannoma management.
Elliott A; Hebb AL; Walling S; Morris DP; Bance M
Am J Otolaryngol; 2015; 36(4):526-34. PubMed ID: 25771841
[TBL] [Abstract][Full Text] [Related]
12. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable?
Quist TS; Givens DJ; Gurgel RK; Chamoun R; Shelton C
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):706-11. PubMed ID: 25628370
[TBL] [Abstract][Full Text] [Related]
13. Hearing Outcomes After Stereotactic Radiosurgery for Jugular Paraganglioma.
Patel NS; Link MJ; Driscoll CLW; Pollock BE; Lohse CM; Carlson ML
Otol Neurotol; 2018 Jan; 39(1):99-105. PubMed ID: 29194225
[TBL] [Abstract][Full Text] [Related]
14. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
15. Vestibular Schwannoma: The Evolution of Hearing and Tumor Size in Natural Course and after Treatment by LINAC Stereotactic Radiosurgery.
Ikonomidis C; Pica A; Bloch J; Maire R
Audiol Neurootol; 2015; 20(6):406-15. PubMed ID: 26571111
[TBL] [Abstract][Full Text] [Related]
16. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
[TBL] [Abstract][Full Text] [Related]
17. Progression of Hearing Loss in Observed Non-Growing Vestibular Schwannoma.
Luryi AL; Babu S; Bojrab DI; Kveton JF; Schutt CA
Otol Neurotol; 2022 Aug; 43(7):e767-e772. PubMed ID: 35763454
[TBL] [Abstract][Full Text] [Related]
18. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
[TBL] [Abstract][Full Text] [Related]
19. Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients With Serviceable Hearing.
Hunter JB; Dowling EM; Lohse CM; O'Connell BP; Tombers NM; Lees KA; Thompson RS; Haynes DS; Carlson ML
Otol Neurotol; 2018 Sep; 39(8):e704-e711. PubMed ID: 30036205
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes in patients treated with CyberKnife radiosurgery for vestibular schwannoma.
Vivas EX; Wegner R; Conley G; Torok J; Heron DE; Kabolizadeh P; Burton S; Ozhasoglu C; Quinn A; Hirsch BE
Otol Neurotol; 2014 Jan; 35(1):162-70. PubMed ID: 24335934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
